Sep 26, 2024, 14:34
Yakup Ergun: Survival and recurrence rates following SBRT or surgery in operable Stage I NSCLC
Yakup Ergun, Medical Oncologist at Antalya City Hospital, shared a post on X, about recent paper published in Lung Cancer:
Survival and recurrence rates following SBRT or surgery in medically operable Stage I NSCLC.
Authors: Michael Snidera, Joseph K. Salama, Matthew Boyer.
”Survival and recurrence rates following SBRT or surgery in operable Stage I NSCLC.
Retrospective, 1:1:1 matching.
Survival rates were better in the lobectomy and sub-lobar resection group compared to SBRT, with lower rates of regional recurrence observed.”
Source: Yakup Ergun/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Oct 9, 2024, 17:29
Oct 9, 2024, 16:51
Oct 9, 2024, 16:49
Oct 9, 2024, 16:46